Ligand validation:4CYF

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4CYF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CYF_NAG_A_603	76%	48%	0.12	0.957	0.71	1.32	1	3	1	0	100%	0.9333
4CYF_NAG_A_602	48%	57%	0.157	0.901	0.43	1.2	-	1	0	0	100%	0.9333
4CYF_NAG_B_602	44%	39%	0.152	0.879	0.44	1.99	-	3	0	0	100%	0.9333
4CYF_NAG_B_601	43%	53%	0.179	0.905	0.41	1.39	-	2	0	0	100%	0.9333
4CYF_NAG_A_601	14%	32%	0.277	0.828	0.49	2.27	-	5	0	0	100%	0.9333
4CYF_NAG_B_603	2%	61%	0.385	0.66	0.52	0.95	-	1	0	0	100%	0.9333
4CYG_NAG_A_1524	81%	56%	0.104	0.956	0.56	1.11	-	2	1	0	100%	0.9333
7SLV_NAG_A_501	51%	69%	0.142	0.896	0.31	0.85	-	1	0	0	100%	0.9333
7SLY_NAG_A_501	32%	72%	0.204	0.877	0.31	0.75	-	1	0	0	100%	0.9333
4CYY_NAG_A_533	26%	47%	0.236	0.879	0.52	1.53	-	3	0	0	100%	0.9333
7SLX_NAG_A_501	23%	70%	0.263	0.884	0.29	0.82	-	1	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.